{"id":902510,"date":"2025-10-29T18:36:24","date_gmt":"2025-10-29T22:36:24","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-report-business-updates-and-third-quarter-2025-financial-and-operating-results-on-november-12-2025\/"},"modified":"2025-10-29T18:36:24","modified_gmt":"2025-10-29T22:36:24","slug":"absci-to-report-business-updates-and-third-quarter-2025-financial-and-operating-results-on-november-12-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-report-business-updates-and-third-quarter-2025-financial-and-operating-results-on-november-12-2025\/","title":{"rendered":"Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">VANCOUVER, Wash. and NEW YORK, Oct.  29, 2025  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_m824CjbwaTAtDMNXKBB1AXVmn8vZYNNDOMP5t5ME0vKON7S_7RhfQ3a9xgRoSC4DPLrPjD3-Q_oz9odS5gSlw==\" rel=\"nofollow\" target=\"_blank\"><u>Absci<\/u><\/a> (Nasdaq: ABSI), a clinical-stage biotech company advancing breakthrough therapeutics with generative AI, today announced the company will report business updates and financial and operating results for the third quarter 2025 after market close on Wednesday, November 12, 2025.<\/p>\n<p align=\"justify\">Absci management will webcast a corresponding conference call beginning at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss its business developments, financial and operating results, and outlook.<\/p>\n<p align=\"justify\">Live audio of the webcast will be available on the company\u2019s investor relations website at: investors.absci.com. The webcast will be archived and available for replay after the event.<\/p>\n<p align=\"justify\">\n        <strong>About Absci<\/strong>\n      <\/p>\n<p align=\"justify\">Absci is advancing the future of drug discovery with generative design to create better biologics for patients, faster. Our Integrated Drug Creation\u2122 platform combines cutting-edge AI models with a synthetic biology data engine, enabling the rapid design of innovative therapeutics that address challenging therapeutic targets. Absci\u2019s approach leverages a continuous feedback loop between advanced AI algorithms and wet lab validation. Each cycle refines our data and strengthens our models, facilitating rapid innovation and enhancing the precision of our therapeutic designs. Alongside collaborations with top pharmaceutical, biotech, tech, and academic leaders, Absci is advancing its own pipeline of AI designed therapeutics. These include ABS-101, a potentially best-in-class antibody to treat inflammatory bowel disease (IBD), as well as other indications, and ABS-201, a groundbreaking innovation in hair regrowth with the potential to redefine treatment possibilities for androgenetic alopecia, commonly known as male and female pattern baldness. Absci is headquartered in Vancouver, WA, with an AI Research Lab in New York City, and Innovation Center in Switzerland. Learn more at <u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gIgzRmj228Sydk1uTCA3CKi2aLfUApb-NmZUAdBO-hY5LisGLBOTeWkNMErasMrsKE2GMPihbxqKLo1COAJRTA==\" rel=\"nofollow\" target=\"_blank\">www.absci.com<\/a><\/u>\u00a0or follow us on LinkedIn (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8tv4KVc2S9xToVVERkAUdOutMCRGm1IDgJVJO9Fsx7ml95r3oH93TnsHZ4WmnCXwoBxCnRz07fOfwfVzFVkUO9vfepw77y4IbTiMS_0VWHU_XWQg4Xgi5vIxJ888WKSkwy9w7aF6vdzu7B5lNdS3FCKApxGVpj9X5YOcLTL_ZG-1OWzVCPm-XG9R75R-JvrY2WZknLHgSmkiMC83DIkLTKEyeyf26zVoU0098xipt8iqStoR7rgE0PHNHuWN0omy\" rel=\"nofollow\" target=\"_blank\"><u>@absci<\/u><\/a>), X (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Xvrct6RmzkhtddczVdlETQns3vdE7j6NVHgyV-g9FLBw3kWPMLI6DJyY_1MiFORirXdlL6cAuGgtdvJuMIS4KU9izCl9NQE5twwlvHnb-d2EV0fFrWtW-1PN_qoOYfIY8sOKOivQsaqm1ySfOQhciEy4yrY4sDA5sxaqPmWqonWNfVw7Cw5fA-q1AhGcEnhjBdeD5l7y6T2sBpm8dLsoVB8agoD_39FCsoHGmGNDXnU=\" rel=\"nofollow\" target=\"_blank\"><u>@Abscibio<\/u><\/a>) and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WzbrGPiuahh3a4BYJ9j6ms-i9fn_QqhXlL5s6JaS5wJoKsENl5mcOxB6xM1qIng2PbYFlZhTvSPdnMs49KvARE8QEd6SK6qNRaQf55s3q1oaw5NJzuyHyN4Ni08iiY4LSFk4O4a0bvvQbbBa4JsVdm1NTAofbr0k1zY2qRkCGWGJgOXKqWEQlmuuKrkhlkcP4UxPBA-uS4hrXA9Lhb-F_QGkL9Z12yfDIUCiB9hjhf8=\" rel=\"nofollow\" target=\"_blank\"><u>YouTube<\/u><\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Investor Contact<\/strong><br \/>\n        <br \/>Alex Khan<br \/>VP, Finance &amp; Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FYbmu2CUUv5XEjnMSV6iHgI6zdzfnGMB7FzdofE9nCENIpqPf3AwIFfsZb4UQ4HXiBeJxC0bYgervmMMm4N8g4A855BVqeaMFkmsYfZ48Cc=\" rel=\"nofollow\" target=\"_blank\">investors@absci.com<\/a><\/p>\n<p align=\"justify\">\n        <strong>Media Contact<\/strong><br \/>\n        <br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NCUWalVxN0iQ5e6VllQFcj7ZkkjNx6gBrmm9ert0rYReJCEvgl-2ufTkEcIywiEUrTCwEbzFL3ZgHwODkMR7nw==\" rel=\"nofollow\" target=\"_blank\">press@absci.com<\/a>\n      <\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NDEwMSM3MjMwNjg1IzIyMTAwODA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MzM3ODMzN2UtNmMxMS00MWIxLTkxNjUtOThlNTI5ZjQxMjYxLTEyMjE2MzMtMjAyNS0xMC0yOS1lbg==\/tiny\/ABSCI-Corporation.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>VANCOUVER, Wash. and NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) &#8212; Absci (Nasdaq: ABSI), a clinical-stage biotech company advancing breakthrough therapeutics with generative AI, today announced the company will report business updates and financial and operating results for the third quarter 2025 after market close on Wednesday, November 12, 2025. Absci management will webcast a corresponding conference call beginning at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss its business developments, financial and operating results, and outlook. Live audio of the webcast will be available on the company\u2019s investor relations website at: investors.absci.com. The webcast will be archived and available for replay after the event. About Absci Absci is advancing the future of drug discovery with generative design &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-report-business-updates-and-third-quarter-2025-financial-and-operating-results-on-november-12-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-902510","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-report-business-updates-and-third-quarter-2025-financial-and-operating-results-on-november-12-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"VANCOUVER, Wash. and NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) &#8212; Absci (Nasdaq: ABSI), a clinical-stage biotech company advancing breakthrough therapeutics with generative AI, today announced the company will report business updates and financial and operating results for the third quarter 2025 after market close on Wednesday, November 12, 2025. Absci management will webcast a corresponding conference call beginning at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss its business developments, financial and operating results, and outlook. Live audio of the webcast will be available on the company\u2019s investor relations website at: investors.absci.com. The webcast will be archived and available for replay after the event. About Absci Absci is advancing the future of drug discovery with generative design &hellip; Continue reading &quot;Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-report-business-updates-and-third-quarter-2025-financial-and-operating-results-on-november-12-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-29T22:36:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NDEwMSM3MjMwNjg1IzIyMTAwODA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-to-report-business-updates-and-third-quarter-2025-financial-and-operating-results-on-november-12-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-to-report-business-updates-and-third-quarter-2025-financial-and-operating-results-on-november-12-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025\",\"datePublished\":\"2025-10-29T22:36:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-to-report-business-updates-and-third-quarter-2025-financial-and-operating-results-on-november-12-2025\\\/\"},\"wordCount\":318,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-to-report-business-updates-and-third-quarter-2025-financial-and-operating-results-on-november-12-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2NDEwMSM3MjMwNjg1IzIyMTAwODA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-to-report-business-updates-and-third-quarter-2025-financial-and-operating-results-on-november-12-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-to-report-business-updates-and-third-quarter-2025-financial-and-operating-results-on-november-12-2025\\\/\",\"name\":\"Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-to-report-business-updates-and-third-quarter-2025-financial-and-operating-results-on-november-12-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-to-report-business-updates-and-third-quarter-2025-financial-and-operating-results-on-november-12-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2NDEwMSM3MjMwNjg1IzIyMTAwODA=\",\"datePublished\":\"2025-10-29T22:36:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-to-report-business-updates-and-third-quarter-2025-financial-and-operating-results-on-november-12-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-to-report-business-updates-and-third-quarter-2025-financial-and-operating-results-on-november-12-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-to-report-business-updates-and-third-quarter-2025-financial-and-operating-results-on-november-12-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2NDEwMSM3MjMwNjg1IzIyMTAwODA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2NDEwMSM3MjMwNjg1IzIyMTAwODA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/absci-to-report-business-updates-and-third-quarter-2025-financial-and-operating-results-on-november-12-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-report-business-updates-and-third-quarter-2025-financial-and-operating-results-on-november-12-2025\/","og_locale":"en_US","og_type":"article","og_title":"Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025 - Market Newsdesk","og_description":"VANCOUVER, Wash. and NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) &#8212; Absci (Nasdaq: ABSI), a clinical-stage biotech company advancing breakthrough therapeutics with generative AI, today announced the company will report business updates and financial and operating results for the third quarter 2025 after market close on Wednesday, November 12, 2025. Absci management will webcast a corresponding conference call beginning at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss its business developments, financial and operating results, and outlook. Live audio of the webcast will be available on the company\u2019s investor relations website at: investors.absci.com. The webcast will be archived and available for replay after the event. About Absci Absci is advancing the future of drug discovery with generative design &hellip; Continue reading \"Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-report-business-updates-and-third-quarter-2025-financial-and-operating-results-on-november-12-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-10-29T22:36:24+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NDEwMSM3MjMwNjg1IzIyMTAwODA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-report-business-updates-and-third-quarter-2025-financial-and-operating-results-on-november-12-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-report-business-updates-and-third-quarter-2025-financial-and-operating-results-on-november-12-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025","datePublished":"2025-10-29T22:36:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-report-business-updates-and-third-quarter-2025-financial-and-operating-results-on-november-12-2025\/"},"wordCount":318,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-report-business-updates-and-third-quarter-2025-financial-and-operating-results-on-november-12-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NDEwMSM3MjMwNjg1IzIyMTAwODA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-report-business-updates-and-third-quarter-2025-financial-and-operating-results-on-november-12-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-report-business-updates-and-third-quarter-2025-financial-and-operating-results-on-november-12-2025\/","name":"Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-report-business-updates-and-third-quarter-2025-financial-and-operating-results-on-november-12-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-report-business-updates-and-third-quarter-2025-financial-and-operating-results-on-november-12-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NDEwMSM3MjMwNjg1IzIyMTAwODA=","datePublished":"2025-10-29T22:36:24+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-report-business-updates-and-third-quarter-2025-financial-and-operating-results-on-november-12-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-report-business-updates-and-third-quarter-2025-financial-and-operating-results-on-november-12-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-report-business-updates-and-third-quarter-2025-financial-and-operating-results-on-november-12-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NDEwMSM3MjMwNjg1IzIyMTAwODA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NDEwMSM3MjMwNjg1IzIyMTAwODA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/absci-to-report-business-updates-and-third-quarter-2025-financial-and-operating-results-on-november-12-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/902510","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=902510"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/902510\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=902510"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=902510"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=902510"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}